Nasdaq · Common stock

Electra Therapeutics (ETRA)

$8.37 −$0.34 (−3.90%)

Day’s range: $8.26–$9.18
Volume: 159,048

Monday’s close

ETRA price history

ETRA closed at $8.37 on Oct. 26, 2026. Over the past year, its daily close ranged from $8.37 on Oct. 26, 2026 to $13.92 on Sept. 21, 2026.

Source: third-party providers. Daily closing prices, adjusted for stock splits; dividends not included. The price scale runs from $8 to $14, not from zero. As of the close on Oct. 26, 2026

Data table: ETRA daily closes, the past year

ETRA daily closing prices, Sept. 18, 2026 to Oct. 26, 2026, newest first
Date	Close
Oct. 26, 2026	$8.37
Oct. 23, 2026	$8.71
Oct. 22, 2026	$9.25
Oct. 21, 2026	$9.05
Oct. 20, 2026	$8.81
Oct. 19, 2026	$8.61
Oct. 16, 2026	$8.75
Oct. 15, 2026	$8.75
Oct. 14, 2026	$8.94
Oct. 13, 2026	$8.61
Oct. 12, 2026	$9.32
Oct. 9, 2026	$9.04
Oct. 8, 2026	$9.14
Oct. 7, 2026	$9.16
Oct. 6, 2026	$9.82
Oct. 5, 2026	$9.74
Oct. 2, 2026	$10.37
Oct. 1, 2026	$10.68
Sept. 30, 2026	$11.25
Sept. 29, 2026	$11.35
Sept. 28, 2026	$11.32
Sept. 25, 2026	$11.55
Sept. 24, 2026	$11.82
Sept. 23, 2026	$12.67
Sept. 22, 2026	$13.62
Sept. 21, 2026	$13.92
Sept. 18, 2026	$13.25

Key figures

Average daily volume: 687,602Past 3 months
Market value: $525.4M
Dividend yield: —

Price change

1 month: −27.53%

Monday’s close

What Wall Street says about ETRA

In the past 90 days, Wall Street firms published 6 rating or price-target actions on ETRA: 6 new ratings.

Rating and price-target actions on ETRA, past 90 days
	Action	Rating
HC Wainwright & Co.	Initiates coverage	Buy	$30	Oct. 23
JP Morgan	Initiates coverage	Overweight	$36	Oct. 22
Cantor Fitzgerald	Initiates coverage	Overweight	—	Oct. 13
Evercore ISI Group	Initiates coverage	Outperform	$36	Oct. 13
Jefferies	Initiates coverage	Buy	$32	Oct. 13
TD Cowen	Initiates coverage	Buy	—	Oct. 13

Ratings and price targets are the firms’ own opinions, reported as published.

Not investment advice.

About Electra Therapeutics, Inc. Common stock

Electra Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on pioneering a new class of precision medicines for the treatment of immune-mediated diseases and cancer.

Listed: Sept. 18, 2026

electra-therapeutics.com, the company’s website

In WallStreetDigest editions

No WallStreetDigest article about ETRA is on the site yet.